Junnan Li, Xin Wang, Shuangnian Xu, Dongfeng Zeng, Yi Yang. "Transition to ixazomib-based maintenance following daratumumab-based induction for continuous therapy in newly diagnosed multiple myeloma." Blood (2025). https://doi.org/10.1182/blood-2025-7517